Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Bioprocess Validation Market Report 2023-2033" has been added to ResearchAndMarkets.com's offering.
World revenue for the Bioprocess Validation Market was forecast to surpass US$490 million in 2023, with strong revenue growth through to 2033.
Rising Demand for Clinical Trials Globally
The market for biopharmaceuticals is rising, there is an increase in the need for healthcare due to an ageing population, and the biotech, pharmaceutical, and medical device industries are expanding to fulfil this demand. As a result, the demand for effective clinical studies has increased in order to ensure the efficacy and safety of products. Worldwide, there are around 266 thousand open clinical trials ongoing. More than 105,000 open clinical investigations are now being conducted just in the United States.
Biologics and other pharmacological medications are the focus of these trials. Positive market growth for clinical trial services has led to an uptick in finance and investment, M&A (merger and acquisition) activity, the use of CROs (contract research organisations), and the availability of functional service providers. Further variables that influence the expansion of the clinical trial services market include the FDA's (Food and Drug Administration) recently implemented simplification of the adoption authorization process, genomics' advancement, and the launch of medicinal products with genetic profiles that are customised to patients or diseases.
Issues Related to Extractables and Leachable
The primary objective of Extractables and Leachables (E&L) testing is to mitigate the potential safety hazards posed to consumers of various products, including pharmaceutical medications and Electronic Nicotine Delivery Systems (ENDS), by evaluating the container closure system of these products. One of the primary difficulties associated with conducting leachables studies pertains to the prevalent necessity of achieving lower detection limits. This poses a challenge for both instrument vendors and laboratory scientists.
The development of instrument methods and sample preparation techniques necessitates the involvement of proficient and knowledgeable analysts who possess advanced skills and extensive experience. This is essential in order to meet the stringent analytical evaluation thresholds. Additionally, the utilisation of cutting-edge mass spectrometry instruments and software is imperative to effectively detect these minute levels and efficiently process the resulting data.
Market Dynamics
Market Driving Factors
- Increasing Demand for Biopharmaceuticals
- Increasing Demand for Outsourcing Bioprocess Validation
- Rising R&D Expenditure
- Rising Demand for Clinical Trials Globally
Market Restraining Factors
- Issues Related to Extractables and Leachable
- High Cost of Advanced Technology
- Shortage of Skilled Labour Post COVID-19 Hampering Industry Growth
- Regulatory Challenges
Market Opportunities
- Growth Opportunities in Emerging Economies
- Harmonized Bioanalytical Testing Opens New Opportunities
- Data Security and Compliance in the Digital Age to Offer Lucrative Growth Prospects
- Customised Solutions for Small and Medium Enterprises (SMEs)
- Digital Twins for Bioprocess Validation
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2033, this new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
Test Type
- Extractable/Leachable Testing
- Microbiological Testing
- Integrity Testing
- Physiochemical Testing
- Compatibility Testing
- Others
Component
- Filters Elements
- Media Containers and Bags
- Freezing and Thawing Process Bags
- Bioreactors
- Transfer Systems
- Others
Modality
- Cell and Gene Therapy
- Vaccines
- Blood and Plasma Products
- Tissue Engineering and Regenerative Medicine
- Others
End-users
- Pharmaceutical Companies
- Biotechnology Companies
- Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets.
The report also includes profiles for the following leading companies, with a focus on this segment of these companies' operations.
- Almac Group
- Charles River Laboratories
- CMIC HOLDINGS Co., Ltd.
- Cobetter Filtration Equipment Co., Ltd.
- Cytovance Biologics
- Cytiva
- DOC S.r.l.
- Eurofins Scientific
- Lonza Group
- Meissner Filtration Products, Inc.
- Merck KGaA
- Sartorius AG
- SGS SA
- Thermo Fisher Scientific Inc.
The report provides you with the following knowledge:
- Revenue forecasts to 2033 for Bioprocess Validation Market 2023 to 2033, with forecasts for test type, component, modality and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 22 key national markets - See forecasts for the Bioprocess Validation Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 14 of the major companies involved in the Bioprocess Validation Market, 2023 to 2033.
For more information about this report visit https://www.researchandmarkets.com/r/nd7ag5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
